Tellgen Corporation (SHE:300642)

Market Cap	2.94B +31.5%
Revenue (ttm)	373.48M -19.3%
Net Income	15.92M -77.5%
EPS	0.10 -77.5%
Shares Out	159.86M
PE Ratio	187.57
Forward PE	n/a
Dividend	0.15 (0.80%)
Ex-Dividend Date	May 20, 2025

Volume	2,193,900
Average Volume	4,974,001
Open	18.85
Previous Close	18.64
Day's Range	18.42 - 18.85
52-Week Range	11.51 - 32.80
Beta	0.44
RSI	40.23
Earnings Date	Apr 25, 2026

About Tellgen

Tellgen Corporation researches and develops, manufactures, and distributes IVDs in China and internationally. The company offers tumor markers; cervical cancer and HPV testing kits; Y chromosome microdeletions test kits; autoimmune; tumor methylation; cardiovascular, eugenics, and inflammation. It also provides diagnostic reagents/testing instruments and assembly lines. The company was founded in 2003 and is based in Shanghai, China.

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2003
• Employees: 522
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 300642

Financial Performance

In 2024, Tellgen's revenue was 436.78 million, a decrease of -19.53% compared to the previous year's 542.81 million. Earnings were 34.53 million, a decrease of -61.37%.